https://www.selleckchem.com/products/Isradipine(Dynacirc).html Diverticular abscess represents a particular therapeutic challenge given the predominant age and frequent co-morbidities of patients presenting with the condition. There has been much interest in the use of minimally invasive techniques such as percutaneous drainage to minimise the morbidity and mortality that is associated with resectional surgery. However, no clear guidance is currently available to suggest which patients should undergo percutaneous drainage versus surgery or for the subsequent management of patients initially treated conservatively. This review of the evidence aimed to provide information for both clinicians and patient to determine the clinical and cost effectiveness of percutaneous drainage versus resectional surgery for the management of diverticular abscess.This review evaluates the evidence for any treatment options for recurrent diverticular disease. These treatment options could be non-pharmacological treatments such as dietary advice or lifestyle changes or could include pharmacological treatment such as analgesia, aminosalicylates and antibiotics. The aim of these treatments would be to reduce the symptoms of diverticular disease and to also prevent future episodes of acute diverticulitis. Patients with diverticular disease are generally given dietary advice to increase fibre intake maintain an adequate fluid intake and maybe avoid certain types of food. The aim of this question was to evaluate the evidence behind these common recommendations. There are currently no medicines routinely used to treat diverticular disease other than potentially recommending bulk forming laxatives if a high fibre diet is insufficient symptom control. Symptoms of diverticular disease often include abdominal pain and analgesia such as paracetamol may be recommended. Generally patients with diverticular disease are advised to avoid non-steroidal anti-inflammatories and opioid based pain killers. Th